Ciclesonide May Be Promising Outpatient Therapy for Early COVID-19
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
In patients with idiopathic pulmonary fibrosis, can supplementation with vitamins C, D, and E affect respiration, inflammation, and oxidative stress?
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
Researchers sought to identify the clinical factors of inflammatory bowel disease and celiac disease that are associated with receiving a positive stool GIPCR test.
In patients with COVID-19, visual assessment of computed tomography images may be useful in predicting the severity of illness.
A meta-trial of 6 clinical trials evaluated the efficacy of awake prone positioning in preventing intubation and death in patients with severe COVID-19.
Researchers evaluated perianal involvement in patients with CD and compared disease course in those with severe vs non-severe perianal CD.
Metformin has demonstrated potential for slowing emphysema progression and its systemic consequences.
High flow nasal cannula oxygen significantly reduced intubation and subsequent invasive mechanical ventilation, but did not affect case fatality in patients with COVID-19 admitted to the ICU for acute respiratory failure.
ASTHMAXcel Adventures is a gamified, guideline-based, pediatric mobile application that improves asthma control, knowledge, and quality of life, and reduces emergency department visits.